ProMIS Neurosciences Inc. (PMN) Live Share Price, Invest From India

ProMIS Neurosciences Inc. Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$11.00
Day's Price Range
$11.50
$11.09
0.81%
Downside
3.70%
Upside
52 Week's Low
52 Week's High
$6.27
52-Week Price Range
$39.75
$11.09
43.46%
Downside
258.43%
Upside

ProMIS Neurosciences Inc. share price movements today

Previous Close: $11.04
Open: $11.15
Volume: 148.6K
Day's Low - High: $11.00 - $11.50
52 Week Low - High: $6.27 - $39.75

ProMIS Neurosciences Inc. Historical Returns

1 Month Return: -11.99 %
3 Month Return: -21.64 %
1 Year Return: -31.19 %
3 Year Return: -93.69 %
5 Year Return: 0 %

ProMIS Neurosciences Inc. Stock Fundamentals & Key Indicators

Check ProMIS Neurosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$98.7M

EPS (TTM)

-6.046

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-13.3M

Revenue (TTM)

7.6K

Profit Margin

0.00%

Return On Equity TTM

-521.60%

ProMIS Neurosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProMIS Neurosciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
ProMIS Neurosciences Inc.	BUY	$98.7M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for ProMIS Neurosciences Inc. Stock including INR - Dollar returns

The ProMIS Neurosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ProMIS Neurosciences Inc. investment value today

Current value as on today

₹78,041

Returns

-₹21,959

(-21.96%)

Returns from ProMIS Neurosciences Inc. Stock

-₹30,688 (-30.69%)

Dollar Impact

₹8,729 (+8.73%)

Analyst Recommendation on ProMIS Neurosciences Inc. Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for ProMIS Neurosciences Inc.. Average target price of $34.86

ProMIS Neurosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on ProMIS Neurosciences Inc..

What analysts predicted

68.19%UPSIDE

Target Price

$34.86

Current Price

$11.09

Analyzed by

6 Analysts

Target

$34.86

ProMIS Neurosciences Inc. target price $34.86, a slight upside of 68.19% compared to current price of $11.09. According to 6 analysts rating.

ProMIS Neurosciences Inc. Stock’s Investor Sentiment and Interest

Search interest for ProMIS Neurosciences Inc. Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 4, 2026 to May 4, 2026

Change:-39% versus previous 30 day period

ProMIS Neurosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	0	-	-	-	-	-	-	-
Gross Profit	0	-	0	-	-	-	-	-	-	-
Operating Income	-2	-3	-3	-2	-4	-6	-7	-10	-11	-10
EBITDA	-2	-	-3	-2	9	0	-7	-10	-11	-11
Interest Expense	0	0	0	-	-	76	-	-	-	-
Depreciation	0	0	-	-	-	-	-	-	-	-
Income Before Tax	-2	-3	-3	-2	9	0	-7	-10	-11	-10
Income Tax Expense	0	-	0	-	-	-	-	-	-	-
Net Income	-1	-3	-3	-2	9	0	-7	-10	-11	-10
Net Profit Margin	0.00%	0.00%	-57929.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

ProMIS Neurosciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	0	0	-	-	-
Gross Profit	0	0	0	-3	-2	-4	-16	-10	-	-
Operating Income	-2	-4	-7	-12	-5	-8	-23	-18	-16	-40
EBITDA	-2	-4	-7	-7	-5	-9	-17	-17	2	-40
Interest Expense	0	0	-	-	-	0	0	0	0	-
Depreciation	-	-	0	0	0	0	0	0	-	-
Income Before Tax	-2	-4	-7	-7	-5	-9	-18	-17	2	-39
Income Tax Expense	0	0	0	-	-	0	-5	0	-	-
Net Income	-1	-3	-5	-5	-4	-7	-13	-17	2	-39,719
Net Profit Margin	-128390.21%	-60838.48%	-2140457.07%	-615329.37%	-361814.19%	-118662.18%	-221930.57%	0.00%	0.00%	0.00%

ProMIS Neurosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	-3	-2	9	0	-7	-10	-11	-39,690
Operating Cash Flow	-	-10	-1	-6	-8	-4	-3	-10	-9
Investing Cash Flow	-	0	-	-	0	-	-	-	0
Financing Cash Flow	-	0	0	27	0	-	-	21	0
Change in Cash	-	-10	-1	20	-8	-4	-3	10	-9

ProMIS Neurosciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-7	-7	-5	-9	-18	-13	2	-39,719
Operating Cash Flow	-4	-6	-6	-4	-9	-17	-10	-27	-28,118
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	5	6	5	3	25	6	17	27	20,944
Change in Cash	0	0	0	0	16	-11	6	0	-7,174

Global Institutional Holdings in ProMIS Neurosciences Inc.

Funds	Holdings
BMO Capital Markets Corp.	0.06%
Howard Financial Services Ltd	0.05%
Citadel Advisors Llc	0.32%
Royal Bank of Canada	0.01%
UBS Group AG	0%

See all

Insights on ProMIS Neurosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 47.0%
NO EFFECT
Against Peers
In the last 3 years, ProMIS Neurosciences Inc has experienced a drawdown of -93.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 86.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, PMN stock has moved down by -12.0%

About ProMIS Neurosciences Inc.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.

Organisation	ProMIS Neurosciences Inc.
Headquarters	1920 Yonge Street, Toronto, ON, Canada, M4S 3E2
Industry	Biotechnology
CEO	Mr. Neil K. Warma M.B.A.
E-voting on shares	Click here to vote

Key Management of ProMIS Neurosciences Inc.

Name	Title
Mr. Daniel E. Geffken M.B.A.	Chief Financial Officer
Dr. David Wishart Ph.D.	Chief Physics Officer
Mr. Dennis Chen Ph.D.	Head of Manufacturing & Senior Consultant
Mr. Eugene W. Williams	Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.	CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.	Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Dr. Johanne Kaplan Ph.D.	Chief Development Officer
Dr. Larry Douglas Altstiel M.D., Ph.D.	Chief Medical Officer

FAQs

What is ProMIS Neurosciences Inc. share price today?

ProMIS Neurosciences Inc. share price today is $11.09 as on May 2, 2026 at 1:29 am IST at the close of the market. ProMIS Neurosciences Inc. share today touched a day high of $11.5 and a low of $11.

What is the 52 week high and 52 week low for ProMIS Neurosciences Inc. share?

ProMIS Neurosciences Inc. share touched a 52 week high of $39.75 on July 21, 2025 and a 52 week low of $6.27 on November 28, 2025. ProMIS Neurosciences Inc. stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $11.09,which is 72.10% down from its 52 week high and 76.87% up from its 52 week low.

What is ProMIS Neurosciences Inc.'s market capitalisation today?

ProMIS Neurosciences Inc. market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in ProMIS Neurosciences Inc. Stock (PMN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ProMIS Neurosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ProMIS Neurosciences Inc. Shares that will get you 0.1353 shares as per ProMIS Neurosciences Inc. share price of $11.09 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy ProMIS Neurosciences Inc. Stock (PMN) from India?

Indian investors can start investing in ProMIS Neurosciences Inc. (PMN) shares with as little as ₹94.91 or $1 (as of May 4, 2026 at 9:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in ProMIS Neurosciences Inc. stock (as per the Rupee-Dollar exchange rate as on May 4, 2026 at 9:37 am IST). Based on ProMIS Neurosciences Inc. share’s latest price of $11.09 as on May 2, 2026 at 1:29 am IST, you will get 0.9017 shares of ProMIS Neurosciences Inc.. Learn more about fractional shares .